Latest news
Halozyme Therapeutics (HALO) Is Up 24.9% After Record Q2, Higher 2026 Guidance And New ENHANZE Deals - Has The Bull Case Changed? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 13:13:58 GMTHalozyme Therapeutics (HALO) Is Up 24.9% After Raising 2026 Revenue Outlook and Boosting Buybacks - Yahoo Finance UKYahoo Finance UK · Sun, 09 Aug 2026 00:19:00 GMTHalozyme (HALO) Stock Rallies As Royalties Surge And Guidance Climbs - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:36:47 GMTHalozyme Therapeutics (NASDAQ:HALO) Upgraded to Strong-Buy at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:55:11 GMTHalozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know - StockStoryStockStory · Sat, 08 Aug 2026 06:48:42 GMTHALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance - TradingViewTradingView · Fri, 07 Aug 2026 22:20:49 GMTHALO Surges As Halozyme Hikes 2026 EPS And Revenue Outlook - StocksToTradeStocksToTrade · Fri, 07 Aug 2026 20:48:00 GMTHalozyme Therapeutics HALO Surges After Big Earnings Beat And Guidance Hike - StocksToTradeStocksToTrade · Fri, 07 Aug 2026 20:17:00 GMT